SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101
Status:
Completed
Trial end date:
2020-04-30
Target enrollment:
Participant gender:
Summary
A randomized, double-blind placebo-controlled first in human study in approximately 36 male
healthy subjects and approximately 20 male and female patients with active UC who have had an
inadequate response to or demonstrated intolerance to 5-ASA.